Crédit Industriel et Commercial’s Apogee Therapeutics APGE Stock Holding History

Crédit Industriel et Commercial’s Portfolio APGE Stock Details APGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.42M	Buy	+63,424	New	+$5.71M	0.54%	40

Other funds holding APGE

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Transmarket Holdings Chicago, Illinois $136M AUM

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Crédit Industriel et Commercial's APGE Position: Q2 2026 in Review

Crédit Industriel et Commercial opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 63,424 shares worth $8.42M. The stake represents 0.54% of the portfolio and ranks #40 among its holdings.

24 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

Crédit Industriel et Commercial held 63,424 shares of Apogee Therapeutics worth $8.42M as of Q2 2026.
Apogee Therapeutics was a new Crédit Industriel et Commercial position in Q2 2026.
Apogee Therapeutics made up 0.54% of Crédit Industriel et Commercial's portfolio in Q2 2026, its #40 holding.
24 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.